GLP-1s have been linked to a lower risk of certain types of cancer in patients with obesity. The specific types of cancer that may have a lower risk include breast, pancreatic, and colorectal cancer. The extent of the link between GLP-1s and lower cancer risk is still being reported, with various studies suggesting potential benefits in different areas, including reduced incidence and spread of cancer.